Skip to content

To Evaluate the Efficacy of Hot Medicated fomentation with Polyherbal formulation in the Management of Non specific Low Back Pain

Evaluation of Efficacy and Safety of Takmid Hot and Dry Medicated fomentation and Qurs e Musakkin in the Management of Non specific Low Back Pain Waja al Zahr - Nill

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093206
Enrollment
44
Registered
2025-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M629- Disorder of muscle, unspecified

Interventions

Intervention1: Takmid (Hot and Dry Medicated fomentation) contains the following ingredients:1 Baboona (Matricaria chamomilla) 2.Marzanjosh (Origanum majorana) 3.Podeena (Mentha spicata) 4.Hasha (Thym

Sponsors

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient willing to give written informed consent. 2 Patients with symptoms consistent with non-specific low back pain these symptoms include back pain and also include stiffness, swelling and difficulty in movement 3 LBP due to faulty posture

Exclusion criteria

Exclusion criteria: Serious systemic illnesses such as Liver, Kidney, Cardiac disorders, Diabetes mellitus, Hypertension, Osteomyelitis, Tuberculosis and Spinal injuries. Pregnant and lactating women. Congenital and degenerative causes of the backache. Spinal deformity like kyphosis, scoliosis, lordosis. Spinal stenosis, lumber spondylosis, tumor infection fracture rheumatoid arthritis trauma, osteoporosis. Patients having wound and severe infection on the back. Unstable, bedridden and mentally retarded patients.

Design outcomes

Primary

MeasureTime frame
1. McGill pain questionnaire.2-18 2. ODI (Oswestry disability index). Timepoint: On day 7,14,21,28 and 35.

Secondary

MeasureTime frame
SF 12 (Quality of life)Timepoint: On day 7,14,21,28 and 35.

Countries

India

Contacts

Public ContactNaziya Noman

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital

mehmoodaanzar@gmail.com7000306293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026